NCT06110377招募中4 期
MALE ANDROGENETIC ALOPECIA - Treatment With Dutasteride Injections: Mesotherapy (Injections With Syringe and Needle) x MMP Technique (Microinjections With Tattoo Machine)
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- HAIR THICKNESS
研究概览
简要总结
This randomized clinical trial carried out on 60 Brazilian men, aged 18 to 65, with mild or moderate androgenetic alopecia. Two techniques for administering dutasteride will be compared, injected by syringes or needles or by needling through tattoo machines.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers male patients.
- •Aged 18 to 65 years.
- •Patients with male androgenetic alopecia (grades III - V of the Norwood/Hamilton scale)
- •Commitment not to initiate any other treatment, topical, systemic or intralesional, that interferes with hair growth during the study period.
- •Patient without systemic treatment for AGA (5 reductase inhibitors) for more than 12 months or without topical treatment for more than 6 months before the start of the study.
- •Allow the creation of two micro tattoos (maximum size of 1 mm each, resembling a hairy infundibulum) in the area that will be treated, in order to standardize the trichoscopic analysis.
- •With the aim of photographic standardization, the patient must agree to have their hair cut in a standardized way in the first and last interventions.
- •Patient about to get his partner pregnant.
- •Patient must refrain from donating blood during the investigation and up to 6 months after the last intervention,
- •Patient must abstain from drinking alcoholic beverages, abstain from using inhaled or injectable drugs, abstain from using illicit drugs within 30 days of entering the study,
- •Patients without a psychiatric diagnosis and who behave appropriately during the interview,
- •Signs of good hygiene and that have the ability to keep the areas undergoing treatment clean until they heal,
- •Patients who understand and speak Portuguese,
- •Patients with realistic expectations regarding the final benefits of treatment,
- •Needle phobia,
- •Independent patient, eliminating the need for tutoring or legal representative,
- •Absence of chronic viral diseases, for example HIV, hepatitis B or hepatitis C,
- •Absence of other skin diseases, for example lichen planus, psoriasis, Crohn's disease or ulcerative colitis,
- •Absence of immunosuppression, for example: lymphoma, transplant therapy, chronic corticosteroid use, Wiskott-Aldrich Syndrome or uncontrolled malignancy,
- •Patients/participants with previously known allergies or those detected during the interventions (anesthetics, topical antibiotics or other medications used in the trials),
- •Absence of clinically significant cardiovascular disease (e.g. previous myocardial infarction), absence of coagulopathy or use of anticoagulants, absence of neurological disease (e.g. stroke, cerebral ischemia), absence of renal, hepatic or endocrine disease (e.g. example, diabetes).
- •Patient/participant with medical conditions not mentioned, which in the investigator's view, prohibit participation in the study.
- •Signature of informed consent
排除标准
- •Detection during the test of allergy to the medicines used (anesthetics, topical antibiotics or other medicines used in the tests),
- •Breach of protocol, inappropriate conduct that compromises participant safety or interferes with the interpretation of study results,
- •Any illness or condition, which in the judgment of the investigators, interferes with the participant's ability to complete or terminate the investigation.
结局指标
主要结局
HAIR THICKNESS
时间窗: 1 year
measurement of the thickness of hair shafts using Trichoscale software (fotofinder)
HAIR DENSITY
时间窗: 1 year
analysis of hair density (number of follicles) per square centimeter using Trichoscale software (fotofinder) and clinical photographs.
次要结局
- Sexual effects(1 year)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
3 期
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyProstatic NeoplasmsNCT03767244Janssen Research & Development, LLC2,517
已完成
2 期
ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual DysfunctionErectile DysfunctionNCT00202163Queen's University120
进行中（未招募）
2 期
Efficacy and Safety of VDPHL01 in Males With AGAAGAMale Pattern BaldnessAndrogenetic AlopeciaNCT06724614Veradermics, Inc.480
尚未招募
Unknown
A study of diffuse hair loss in males & comparision of treatment modalities like PRP with minoxidil & finasterideCTRI/2023/04/051903Santosh medical college and hospital
进行中（未招募）
不适用
Trial investigating hormone injections, external beam radiotherapy and intravenous radionuclide injection in patients with advanced prostate cancer.Metastatic castration sensitive prostate cancerEUCTR2014-000273-39-GBBelfast Health and Social Care Trust